Medindia
Medindia LOGIN REGISTER
Advertisement

Faced with Global Acetonitrile Shortage, Analytical Labs Turn to ACQUITY UPLC to Reduce Acetonitrile Use by at least 70 Percent

Tuesday, December 16, 2008 General News
Advertisement
MILFORD, Mass., Dec. 16 With the analyticalindustry experiencing its most severe acetonitrile shortage in history,pharmaceutical, food, environmental and chemical industries are all searchingfor solutions to maintain their mission critical laboratory productivity.Waters Corporation (NYSE: WAT), working with its key customers, todayestimated that replacing traditional high performance LC (HPLC) with Waters(R)ACQUITY(R) UltraPerformance LC(R) (UPLC(R)) reduces acetonitrile consumptionby at least 70 percent without compromising productivity and performance.
Advertisement

"The time for ACQUITY UPLC adoption has never been clearer," said RohitKhanna, Vice President of Global Marketing for the Waters Division."Laboratory-dependent businesses and government agencies around the world arefacing difficult decisions because there is simply not enough acetonitrileavailable to efficiently run their labs using traditional liquidchromatography technology. As these organizations evaluate their options, theinnovations behind UPLC technology provide the best solution to today's crisisand safeguarding against future risk."
Advertisement

The ACQUITY UPLC System allows scientists to perform required analysis,such as quality assurance and quality control tests, using less resource thanHPLC. Because the system operates with a wider velocity range, higher flowrates, and greater backpressures, UPLC uses significantly less solvent,including acetonitrile. The result is the ability to maintain or improve labproductivity and performance, with reduced costs and reduced externalpressures associated with the current acetonitrile shortages.

For more information on ACQUITY UPLC, method validation, and related casestudies, please visit: http://www.waters.com/acn.

About Waters Corporation: (http://www.waters.com)

Waters Corporation creates business advantage for laboratory-dependentorganizations by delivering practical and sustainable innovation to enablesignificant advancements in such areas as healthcare delivery, environmentalmanagement, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratoryinformation management, mass spectrometry and thermal analysis, Waterstechnology breakthroughs and laboratory solutions provide an enduring platformfor customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters isdriving scientific discovery and operational excellence for customersworldwide.

Waters, UltraPerformance LC, UPLC, and ACQUITY UPLC are trademarks ofWaters Corporation.Investor Contact: Gene Cassis Corporate Vice President, Worldwide Business Development Waters Corporation Ph: 508-482-2349 Media Contact: Brian J. Murphy Public Relations Manager Waters Corporation Ph: 508-482-2614

SOURCE Waters Corporation
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close